Areva and the industrial company Mirion Technologies on 1 July completed the sale to Mirion of Canberra, Areva’s nuclear instrumentation and measurement specialist employing approximately 1,000 staff. In December 2015, Mirion was selected by Areva after a competitive process. Areva and Mirion subsequently entered into a Share Purchase Agreement to acquire the entire share capital of Canberra. Thomas D Logan, Mirion’s Chairman and CEO, said the combination of Mirion and Canberra” creates a premier supplier of radiation safety solutions for the nuclear, defence and medical industries”.
Areva and the industrial company Mirion Technologies on 1 July completed the sale to Mirion of Canberra, Areva’s nuclear instrumentation and measurement specialist employing approximately 1,000 staff. In December 2015, Mirion was selected by Areva after a competitive process. Areva and Mirion subsequently entered into a Share Purchase Agreement to acquire the entire share capital of Canberra. Thomas D Logan, Mirion’s Chairman and CEO, said the combination of Mirion and Canberra" creates a premier supplier of radiation safety solutions for the nuclear, defence and medical industries".
Areva CEO Philippe Knoche said: "The sale of Canberra to Mirion is in line with our previously announced restructuring plan and our strategic roadmap released in June. Mirion was chosen by Areva in part because of its long history as a reliable supplier to the nuclear industry, its track record of creating and maintaining highly skilled jobs in France and its strong financial backing. The timely closing of this transaction is a testament to our commitment to pursuing Areva’s transformation."